SCHOFIELD, Wis., Nov. 28, 2011 (GLOBE NEWSWIRE) -- PuraMed BioScience, Inc. (OTCBB:PMBS) announced today that their new non-prescription migraine medication, LipiGesic™ M, is now available for sale nationwide at the number one chain of drugstores in the United States, Walgreens.
Walgreens, with its over 7,700 locations is the nation's largest drugstore chain and is the only chain to operate in all 50 states as well as the District of Columbia and Puerto Rico.
PuraMed BioScience CEO, Russ Mitchell, stated, "We continue to execute our expansion strategy to seek strong penetration in mass retail channels, and now with distribution in Walgreens, our LipiGesic™ M product is even more accessible to the more than 50 million migraine sufferers in the U.S. alone."
About the PuraMed BioScience, Inc.:
PuraMed BioScience, Inc. engages in the research, development and marketing of non-prescription medicinal and healthcare products. In addition to its leading product LipiGesic™ M, which provides acute relief from migraine headaches; the Company also has plans to launch LipiGesic™ PM that provides a remedy for insomnia and other sleep disorders as well as LipiGesic™ H for common tension headaches. For more information on PuraMed, visit the Company website at www.PuraMedBioScience.com, join the Company's group page on Facebook by searching "PuraMed BioScience".
Forward-Looking Statements:
This news release contains forward-looking statements regarding PuraMed BioScience and its future business plans, which statements involve known and unknown risks and uncertainties. Such risks and uncertainties may cause actual results and future achievements of PuraMed BioScience to be materially different than those implied by these forward-looking statements. PuraMed BioScience has and undertakes no obligation to provide public updates and revisions to these forward-looking statements to reflect any changes in its expectations of future events.